Combination of Human Leukocyte Antigen and Killer Cell Immunoglobulin-Like Receptor Genetic Background Influences the Onset Age of Hepatocellular Carcinoma in Male Patients with Hepatitis B Virus Infection

Author:

Pan Ning12,Qiu Jie23,Sun Hang2,Miao Fengqin12,Shi Qian2,Xu Jinhuan2,Jiang Wei2,Jin Hui4,Xie Wei12,He Youji1,Zhang Jianqiong12

Affiliation:

1. Department of Pathogenic Biology and Immunology, Southeast University Medical School, 87 Dingjiaqiao Road, Nanjing, Jiangsu 210009, China

2. Key Laboratory of Developmental Genes and Human Disease, Ministry of Education, Southeast University, Nanjing, Jiangsu 210009, China

3. The Second Affiliated Hospital of Southeast University, Nanjing, Jiangsu 210000, China

4. Department of Epidemiology, School of Public Health, Southeast University, Nanjing, Jiangsu 210009, China

Abstract

To investigate whether killer cell immunoglobulin-like receptor(KIR)and human leukocyte antigen(HLA)genetic background could influence the onset age of hepatocellular carcinoma (HCC) in patients with hepatitis B virus (HBV) infection, one hundred and seventy-one males with HBV-related HCC were enrolled. The presence of 12 loci ofKIRwas detected individually.HLA-A, -B, and -Cloci were genotyped with high resolution by a routine sequence-based typing method. The effect of eachKIRlocus,HLAligand, andHLA-KIRcombination was examined individually by Kaplan-Meier (KM) analysis. Multivariate Cox hazard regression model was also applied. We identifiedC1C1-KIR2DS2/2DL2as an independent risk factor for earlier onset age of HCC (median onset age was 44 forC1C1-KIR2DS2/2DL2positive patients compared to 50 for negative patients,P=0.04for KM analysis; HR = 1.70,P=0.004for multivariate Cox model). We conclude thatKIRandHLAgenetic background can influence the onset age of HCC in male patients with HBV infection. This study may be useful to improve the current HCC surveillance program in HBV-infected patients. Our findings also suggest an important role of natural killer cells (or otherKIR-expressing cells) in the progress of HBV-related HCC development.

Funder

National Natural Science Foundation of China

Publisher

Hindawi Limited

Subject

General Medicine,Immunology,Immunology and Allergy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3